tracken
monday.com Aktie News
Negativ
The Motley Fool
●
2 Tage alt
At first blush, this was mysterious, as it posted an outwardly good-looking third quarter. Investors were focused on a revenue guidance miss, however.
Neutral
Seeking Alpha
●
3 Tage alt
Small-cap stocks extended their momentum into the third quarter. We believe Rambus' evolution from a licensing and patent company into a full-fledged product company is progressing well. Shake Shack stock pulled back following quarterly results that did not meet elevated expectations.
Positiv
Seeking Alpha
●
4 Tage alt
Esperion Therapeutics, Inc. and C4 Therapeutics, Inc. were among the top contributors to performance. SiTime Corp. was also a top contributor. The company provides silicon timing chips for a wide range of electronics. The greatest detractor from Fund performance for the quarter was Monday.com Ltd.
Neutral
Seeking Alpha
●
6 Tage alt
monday.com Ltd. ( MNDY ) Q3 2025 Earnings Call November 10, 2025 8:30 AM EST Company Participants Byron Stephen - Director of Investor Relations Roy Mann - Co-Founder, Co-CEO & Director Eran Zinman - Co-Founder, Co-CEO & Director Eliran Glazer - Chief Financial Officer Casey George - Chief Revenue Officer Conference Call Participants Kasthuri Rangan - Goldman Sachs Group, Inc., Research Divisio...
Negativ
MarketBeat
●
6 Tage alt
Monday.com's NASDAQ: MNDY Q3 earnings release provided an excuse to sell, but the 20% decline posted in premarket action is an overreaction of epic proportions. The cause was guidance.
Positiv
The Motley Fool
●
6 Tage alt
Monday.com reported solid results, but a small revenue guidance cut pushed the stock lower. The company's overall strategy is working, but investors may be concerned about a potential slowdown.
Positiv
The Motley Fool
●
6 Tage alt
Monday.com's third-quarter revenue jumped 26%, and earnings beat Wall Street estimates by a wide margin. The stock still plunged over 20% because fourth-quarter guidance came in below analyst expectations.
Negativ
Invezz
●
6 Tage alt
Monday.com Ltd (NASDAQ: MDNY) opened nearly 20% down on Monday morning after posting a better-than-expected Q3 but offering disappointing guidance for its current financial quarter. While bulls would argue the strong headline numbers warrant buying MDNY shares on the post-earning slump, a deeper dive into both the fundamentals and technicals suggest otherwise.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
